Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sb623 (3 trials)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Cerebral Infarction (Phase 2)
Ischemia (Phase 2)
Stroke (Phase 2)
Wounds and Injuries (Phase 2)
Trials (3 total)
Trial APIs (1 total)